Clinical Trial Update: Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis [NA]

View source ↗

Summary

A completed clinical trial investigates whether oral vitamin C affects erythropoietin dosing requirements in patients with end-stage renal disease on regular he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Erythropoietin (erythropoietin)
• Vitamin C (ascorbic acid)

Snippet

Sponsor: Ain Shams University | Conditions: Vitamin C, Oral Administration | NA | Status: COMPLETED